단백질 발현 시장 : 시스템별, 제공별, 용도별, 최종사용자별 - 세계 예측(-2030년)

Protein Expression Market by System (Mammalian, Non-mammalian ), Offering (Kits & Reagents, Vectors, Competent Cells, Services), Application (Industrial, Therapeutic, Research), and End User - Global Forecast to 2030

US $ 4,175 ￦ 5,796,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,875 ￦ 8,156,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,875 ￦ 10,932,000

PDF (Global Site License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

단백질 발현 시장은 2023년부터 2030년까지 7.6%의 CAGR로 2030년까지 50억 달러에 달할 것으로 예상됩니다.

본 보고서는 광범위한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 기회 및 도전 과제에 대한 분석을 제공합니다.

바이오의약품 시장의 성장, 재조합 단백질에 대한 수요 증가, 정부 지원책, 생명과학 연구 자금 지원 등이 이 시장의 성장을 촉진하고 있습니다. 그러나 단백질 기반 연구에 소요되는 높은 비용과 숙련된 전문가의 부족은 이 시장의 성장을 저해하는 요인으로 작용하고 있습니다. 또한, 신흥국은 단백질 발현 시장에서 활동하는 기업들에게 큰 성장 기회를 제공할 것으로 예상됩니다. 그러나 실험실에서 형질전환 매개변수의 복잡성이 시장 성장을 제한하는 요인으로 작용하고 있습니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

• 시장 개요
• 성장 촉진요인
  • 바이오의약품 시장 성장
  • 재조합 단백질에 대한 수요 증가
  • 생명과학 연구에 대한 정부 이니셔티브와 자금 증가
• 성장 억제요인
  • 숙련 전문가의 부족
  • 단백질 기반 연구의 높은 비용
• 기회
  • 잠재적 신흥 경제국
• 과제
  • 실험실에서 변환 파라미터의 복잡성
• 업계 동향
• 상부/인접 시장 분석
• 규제 분석

제5장 단백질 발현 시장 평가 : 시스템별

• 개요
• 포유류 세포 발현 시스템
  • 중국 햄스터 난소(CHO) 세포주
  • HEK 293 세포주
  • 기타 포유류 세포주
• 비포유류 세포 발현 시스템
  • 세균 세포주
  • 곤충 세포주
  • 효모 세포주
  • 식물 세포주
  • 조류 세포주
• 무세포 발현 시스템

제6장 단백질 발현 시장 평가 : 제품 및 서비스별

• 개요
• 기기
• 키트·시약
• 컴피턴트 세포
  • 화학적 컴피턴트 세포
  • 전기적 컴피턴트 세포
• 발현 벡터
• 서비스

제7장 단백질 발현 시장 평가 : 용도별

• 개요
• 치료 용도
• 산업 응용
• 연구 용도

제8장 단백질 발현 시장 평가 : 최종사용자별

• 소개
• 제약·바이오테크놀러지 산업
• 임상시험수탁기관(CRO)
• 학술·연구기관

제9장 단백질 발현 시장 평가 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 기타 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 분석

• 개요
• 주요 성장 전략
• 경쟁 벤치마킹
• 경쟁 대시보드
  • 업계 리더
  • 시장 차별화 요인
  • 선행 기업
  • 신흥 기업
• 시장 점유율 분석(2022년)

제11장 기업 개요(기업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개)

• Thermo Fisher Scientific Inc.
• Promega Corporation
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Takara Holdings Inc.
• GenScript Biotech Corporation
• Qiagen N.V.
• Agilent Technologies, Inc.
• Danaher Corporation
• BECTON, DICKINSON AND COMPANY

(참고 : 상위 5개사 SWOT 분석을 제공 예정입니다)

제12장 부록

ksm

영문 목차

영문목차

Protein Expression Market Size, Share, Forecast, & Trends Analysis by System (Mammalian [CHO, HEK 293], Non-mammalian [Bacterial, Insect]), Offering (Kits & Reagents, Competent Cells, Services), Application, and End User - Global Forecast to 2030

The protein expression market is projected to reach $5 billion by 2030 at a CAGR of 7.6% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growing biopharmaceutical market, the rising demand for recombinant proteins, supportive government initiatives, and funding for life science research are driving the growth of this market. However, the high costs of protein-based research and the lack of skilled professionals restrain the growth of this market. Furthermore, emerging economies are expected to offer significant growth opportunities for players operating in the protein expression market. However, complexities in laboratory transformation parameters are a challenge limiting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the protein expression market are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Takara Holdings Inc. (Japan), GenScript Biotech Corporation (U.S.), Qiagen N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), and Becton, Dickinson and Company (U.S.).

Based on system, in 2023, the Chinese Hamster Ovary (CHO) cell line segment is expected to account for the largest share of the mammalian protein expression market. The large market share of this segment is attributed to the popularity of CHO cell lines in the production of biologics, the high similarity of CHO cells to the human cell system, and the high reproducibility of CHO cells.

Based on offering, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the increasing outsourcing of operations by pharma & biotech companies, the rising demand for biopharmaceuticals, collaborations between industry and academia for rapid bioproduction, and the growing demand for recombinant proteins in the non-healthcare sector.

Based on application, in 2023, the therapeutic segment is estimated to account for the largest share of the protein expression market. The large market share of this segment is attributed to the increasing incidence of diseases requiring therapeutic approaches for treatment and growth in R&D for therapeutic protein production.

Based on end user, in 2023, the contract research organizations segment is estimated to account for the largest share of the protein expression market. The large market share of this segment can be attributed to the increase in research activities and growth in outsourcing for the development of biologics.

An in-depth analysis of the geographical scenario in the protein expression market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the protein expression market. Furthermore, in 2023, the U.S. is expected to account for the major share of the protein expression market in North America. The large share of this market is primarily attributed to the presence of key market players, growth in R&D activities, and the significant volume of bioproduction.

Scope of the Report:

Protein Expression Market Assessment-by System

• Mammalian Cell Expression Systems
  • Chinese Hamster Ovary (CHO) Cell Lines
  • HEK 293 Cell Lines
  • Other Mammalian Cell Lines
• Non-mammalian Cell Expression Systems
  • Bacterial Cell Lines
  • Insect Cell Lines
  • Yeast Cell Lines
  • Plant Cell Lines
  • Algal-based Cell Lines
• Cell-free Expression System

Note: Other mammalian cell lines include baby hamster kidney cells, non-secreting murine myeloma cells, and PER.C6.

Protein Expression Market Assessment-by Offering

• Instruments
• Kits & Reagents
• Competent Cells
  • Chemically Competent Cells
  • Electrocompetent Cells
• Expression Vectors
• Services

Protein Expression Market Assessment-by Application

• Therapeutic
• Research
• Industrial

Protein Expression Market Assessment-by End User

• Pharmaceutical & Biotechnology Industry
• Contract Research Organizations
• Academic & Research Institutes

Protein Expression Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

• 4.1. Market Overview
• 4.2. Drivers
  • 4.2.1. Growth in the Biopharmaceutical Market
  • 4.2.2. Growing Demand for Recombinant Proteins
  • 4.2.3. Rising Government Initiatives and Funding for Life Science Research
• 4.3. Restraints
  • 4.3.1. Shortage of Skilled Professionals
  • 4.3.2. High Cost of Protein-based Research
• 4.4. Opportunities
  • 4.4.1. Potential Emerging Economies
• 4.5. Challenges
  • 4.5.1. Complexities in Laboratory Transformation Parameters
• 4.6. Industry Trends
• 4.7. Parent/Adjacent Market Analysis
• 4.8. Regulatory Analysis

5. Protein Expression Market Assessment-by System

• 5.1. Overview
• 5.2. Mammalian Cell Expression System
  • 5.2.1. Chinese Hamster Ovary (CHO) Cell Lines
  • 5.2.2. HEK 293 Cell Lines
  • 5.2.3. Other Mammalian Cell Lines
• 5.3. Non-mammalian Cell Expression System
  • 5.3.1. Bacterial Cell Lines
  • 5.3.2. Insect Cell Lines
  • 5.3.3. Yeast Cell Lines
  • 5.3.4. Plant Cell Lines
  • 5.3.5. Algal Cell Lines
• 5.4. Cell-Free Expression System

6. Protein Expression Market Assessment-by Product & Services

• 6.1. Overview
• 6.2. Instruments
• 6.3. Kits & Reagents
• 6.4. Competent Cells
  • 6.4.1. Chemically Competent Cells
  • 6.4.2. Electrocompetent Cells
• 6.5. Expression Vectors
• 6.6. Services

7. Protein Expression Market Assessment-by Application

• 7.1. Overview
• 7.2. Therapeutic Application
• 7.3. Industrial Application
• 7.4. Research Application

8. Protein Expression Market Assessment-by End User

• 8.1. Introduction
• 8.2. Pharmaceutical and Biotechnology Industry
• 8.3. Contract Research Organizations (CROs)
• 8.4. Academic and Research Institutes

9. Protein Expression Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. India
  • 9.4.3. Japan
  • 9.4.4 Rest of Asia-Pacific
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share Analysis (2022)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments)

• 11.1. Thermo Fisher Scientific Inc.
• 11.2. Promega Corporation
• 11.3. Merck KGaA
• 11.4. Bio-Rad Laboratories, Inc.
• 11.5. Takara Holdings Inc.
• 11.6. GenScript Biotech Corporation
• 11.7. Qiagen N.V.
• 11.8. Agilent Technologies, Inc.
• 11.9. Danaher Corporation
• 11.10. BECTON, DICKINSON AND COMPANY

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports

관련자료